Hillman Capital Management, Inc. is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q4 2025, the fund manages $159M in reported equity holdings across 56 positions. The largest holdings are WBD (3.9%), ASML (3.7%), EL (3.6%), CVS (3.6%), GSK (3.5%). The portfolio is concentrated in Other (84.8%), Technology (5.5%), Communication Services (3.9%). Data sourced from SEC EDGAR 13F filings (CIK 1314620).